146 related articles for article (PubMed ID: 24738098)
1. Basal cell carcinoma: analysis of factors associated with incomplete excision at a referral hospital in southern Spain.
Husein-Elahmed H; Aneiros-Fernandez J; Gutierrez-Salmeron MT; Aneiros-Cachaza J; Naranjo-Sintes R
Cutis; 2014 Mar; 93(3):155-61. PubMed ID: 24738098
[TBL] [Abstract][Full Text] [Related]
2. Management of periocular basal and squamous cell carcinoma: a series of 485 cases.
Nemet AY; Deckel Y; Martin PA; Kourt G; Chilov M; Sharma V; Benger R
Am J Ophthalmol; 2006 Aug; 142(2):293-7. PubMed ID: 16876511
[TBL] [Abstract][Full Text] [Related]
3. Positive compared with negative margins in a single-centre retrospective study on 3957 consecutive excisions of basal cell carcinomas. Associated risk factors and preferred surgical management.
Codazzi D; Van Der Velden J; Carminati M; Bruschi S; Bocchiotti MA; Di Serio C; Barberis M; Robotti E
J Plast Surg Hand Surg; 2014 Feb; 48(1):38-43. PubMed ID: 23731130
[TBL] [Abstract][Full Text] [Related]
4. Incomplete excision of basal cell carcinoma: rate and associated factors among 362 consecutive cases.
Farhi D; Dupin N; Palangié A; Carlotti A; Avril MF
Dermatol Surg; 2007 Oct; 33(10):1207-14. PubMed ID: 17903153
[TBL] [Abstract][Full Text] [Related]
5. Incomplete primary excision of cutaneous basal and squamous cell carcinomas in the Bay of Plenty.
Talbot S; Hitchcock B
N Z Med J; 2004 Apr; 117(1192):U848. PubMed ID: 15107870
[TBL] [Abstract][Full Text] [Related]
6. An assessment of incomplete facial Basal cell carcinoma excision.
Shah SA; Obaidullah ; Fahimullah
J Coll Physicians Surg Pak; 2005 Mar; 15(3):149-51. PubMed ID: 15808092
[TBL] [Abstract][Full Text] [Related]
7. Factors contributing to incomplete excision of nonmelanoma skin cancer by Australian general practitioners.
Hansen C; Wilkinson D; Hansen M; Soyer HP
Arch Dermatol; 2009 Nov; 145(11):1253-60. PubMed ID: 19917954
[TBL] [Abstract][Full Text] [Related]
8. Surgical excision of basal cell carcinoma with complete margin control: outcome at 5-year follow-up.
Wetzig T; Woitek M; Eichhorn K; Simon JC; Paasch U
Dermatology; 2010; 220(4):363-9. PubMed ID: 20484877
[TBL] [Abstract][Full Text] [Related]
9. Basosquamous cell carcinoma: a survey of 76 patients and a comparative analysis of basal cell carcinomas and squamous cell carcinomas.
Betti R; Crosti C; Ghiozzi S; Cerri A; Moneghini L; Menni S
Eur J Dermatol; 2013; 23(1):83-6. PubMed ID: 23238332
[TBL] [Abstract][Full Text] [Related]
10. Incompletely excised basal cell carcinoma: residual tumor rates at Mohs re-excision.
Palmer VM; Wilson PR
Dermatol Surg; 2013 May; 39(5):706-18. PubMed ID: 23294110
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the treatment of non-melanoma skin cancers by surgical excision.
Pua VS; Huilgol S; Hill D
Australas J Dermatol; 2009 Aug; 50(3):171-5. PubMed ID: 19659977
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for orbital exenteration in periocular Basal cell carcinoma.
Iuliano A; Strianese D; Uccello G; Diplomatico A; Tebaldi S; Bonavolontà G
Am J Ophthalmol; 2012 Feb; 153(2):238-241.e1. PubMed ID: 21982108
[TBL] [Abstract][Full Text] [Related]
13. Incidence of residual nonmelanoma skin cancer in excisions after shave biopsy.
Grelck K; Sukal S; Rosen L; Suciu GP
Dermatol Surg; 2013 Mar; 39(3 Pt 1):374-80. PubMed ID: 23279620
[TBL] [Abstract][Full Text] [Related]
14. Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: a randomized controlled trial with at least 5-year follow-up.
Roozeboom MH; Aardoom MA; Nelemans PJ; Thissen MR; Kelleners-Smeets NW; Kuijpers DI; Mosterd K
J Am Acad Dermatol; 2013 Aug; 69(2):280-7. PubMed ID: 23566914
[TBL] [Abstract][Full Text] [Related]
15. Basal cell carcinomata: Risk factors for incomplete excision and results of re-excision.
Masud D; Moustaki M; Staruch R; Dheansa B
J Plast Reconstr Aesthet Surg; 2016 May; 69(5):652-6. PubMed ID: 26948998
[TBL] [Abstract][Full Text] [Related]
16. Scalp Basal Cell Carcinoma: Review of 2,202 Cases.
Cho M; Lee J; James CL; Marshman G; Huilgol SC
Dermatol Surg; 2016 Jul; 42(7):834-41. PubMed ID: 27243131
[TBL] [Abstract][Full Text] [Related]
17. Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years.
Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
J Am Acad Dermatol; 2005 Sep; 53(3):445-51. PubMed ID: 16112351
[TBL] [Abstract][Full Text] [Related]
18. Clinical and pathologic parameters predicting recurrence of facial basal cell carcinoma: a retrospective audit in an advanced care center.
Troeltzsch M; Probst FA; Knösel T; Mast G; Ehrenfeld M; Otto S
Int J Dermatol; 2016 Nov; 55(11):1281-1288. PubMed ID: 27420481
[TBL] [Abstract][Full Text] [Related]
19. Long-term prognosis after surgical excision of basal cell carcinoma: a single institutional study in Japan.
Takenouchi T; Takatsuka S
J Dermatol; 2013 Sep; 40(9):696-9. PubMed ID: 23803167
[TBL] [Abstract][Full Text] [Related]
20. Nasal basal cell carcinomas. Can we reduce surgical margins to 3mm with complete excision?
Konopnicki S; Hermeziu O; Bosc R; Abd Alsamad I; Meningaud JP
Ann Chir Plast Esthet; 2016 Aug; 61(4):241-7. PubMed ID: 26879668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
